Leveraged & Inverse Channel Biotech ETFs Hoping This Post-Election Trend Doesn’t Repeat By Brenton GarenNovember 8, 2018
Leveraged & Inverse Channel After a Rough October, Leveraged Biotech ETF Looks to Bounce Back By Brenton GarenNovember 6, 2018
Equity ETFs As Election Day Arrives, Is It Finally Time to Buy Biotech ETFs? By Tom LydonNovember 8, 2016
Equity ETFs Clinton Mylan Attack Reminds Biotech ETF Investors of Election Risks By Max ChenAugust 25, 2016